C
Cyclo Therapeutics D
D
CYTH
0.88650
USD
-0.06
(-5.98%)
مغلق
حجم التداول
2,941
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
29,020,738
المقالات
العنوان: Cyclo Therapeutics
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.